Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: $0.165

$0.165

posted on Jul 07, 2008 08:23AM

That's all that matters. Regardless of how it got there (whatever BoD or ex-CEO you blame), the share price is sixteen and a half cents.

Market cap is around $65M by my count. So the question is, forgetting the past, if you stumbled on PTSC today would it be a buy?

Ignore past promises, past potential, and time spent on this one. Today is all that matters. Is it worth $65M? Or more or less?

(it ticked to $0.17, question remains the same)











Share
New Message
Please login to post a reply